Procalcitonin to C-reactive protein ratio is associated with short-term mortality in ischemic stroke patients: preliminary report

Introduction: Inflammation is associated with the development and progression of ischemic stroke. In this study, we tested the diagnostic ability of procalcitonin (PCT) to C-reactive protein (CRP) ratio (PC ratio; ×10 -6 ) to predict 90-day mortality in ischemic stroke patients. Material and

Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital, BMC Geriatrics

Frontiers Association between the C-reactive protein to albumin ratio and adverse clinical prognosis in patients with young stroke

Diseases, Free Full-Text

Procalcitonin related to stroke-associated pneumonia and clinical outcomes of acute ischemic stroke after IV rt-PA treatment

Procalcitonin Is a Stronger Predictor of Long-Term Functional Outcome and Mortality than High-Sensitivity C-Reactive Protein in Patients with Ischemic Stroke

Receiver operating characteristic curve analysis of PCT and CRP for

Kaplan‐Meier survival curves according to procalcitonin (PCT) at

High-sensitivity C-reactive protein in stroke patients – The importance in consideration of influence of multiple factors in the predictability for disease severity and death

Procalcitonin as a Biomarker for Malignant Cerebral Edema in Massive Cerebral Infarction